OCUL | Ocular Therapeutix Inc
Category: Consumer goods
Quick infos Headquarters: Bedford, Massachusetts, United States Trade prices Volume: Market Cap: 313.95M Prev closed: Open: 4.92 High: 4.99 Low: 4.66 52 week low: 4.66 52 week high: 19.84 Dividends: No Dividends Next ER: May 8, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast August 7, 2023 May 8, 2023 -0.39 / -0.2613.37M / 14.07MMarch 6, 2023 -0.24 / -0.2514.1M / 13.42MBeat! November 7, 2022 -0.31 / -0.238311.97M / 14.27MAugust 8, 2022 -0.25 / -0.22212.27M / 14.25Mview more
Historical Data Date Price Open High Low Vol Change ER May 5, 2023 6.25 6.15 6.3
6.1
900K 2.63% May 4, 2023 6.09 6.2 6.25
5.9
724K -1.62% May 3, 2023 6.19 6.03 6.26
6.02
773K 3.69% May 2, 2023 5.97 6.15 6.2
5.93
651K -3.4% May 1, 2023 6.18 6.16 6.32
6.15
951K -0.32% Apr 28, 2023 6.2 6.01 6.28
5.91
974K 3.16% Apr 27, 2023 6.01 6.06 6.06
5.81
491K 0% Apr 26, 2023 6.01 5.87 6.06
5.82
618K 1.86% Apr 25, 2023 5.9 6.19 6.23
5.84
892K -4.84% Apr 24, 2023 6.2 6.45 6.67
6.11
1.7M -3.58% view more
NASDAQ - Nasdaq Stock Market
News
Ocular Therapeutix stock rises after posting Q4 results beat, strong guidance seekingalpha.com Mar 8, 2023 4:39 am Ocular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensus seekingalpha.com Mar 7, 2023 5:04 am Ocular Therapeutix Q4 2022 Earnings Preview seekingalpha.com Mar 6, 2023 6:35 am
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised) finance.yahoo.com Dec 7, 2022 5:25 pm
Ocular Therapeutix Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD finance.yahoo.com Dec 7, 2022 6:00 am
Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates (Revised) finance.yahoo.com Dec 7, 2022 5:38 am Here's Why Ocular Therapeutix Stock Is Sinking Today fool.com Sep 30, 2022 11:25 am Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint thestreet.com Sep 30, 2022 9:31 am 3 Biotech Stocks That Could Rise 90% or More, According to Wall Street fool.com Sep 30, 2022 6:21 am Ocular stock rises ~15% as eye drug implant shows promise in ongoing phase 1 trial seekingalpha.com Feb 13, 2023 6:05 pm
These Analysts Just Made A Neat Downgrade To Their Ocular Therapeutix, Inc. (NASDAQ:OCUL) EPS Forecasts finance.yahoo.com Nov 13, 2022 7:10 am Ocular Therapeutix hits 52-week low after slashing revenue guidance seekingalpha.com Nov 9, 2022 2:13 am Ocular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlook seekingalpha.com Nov 9, 2022 1:56 am Ocular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3M seekingalpha.com Nov 8, 2022 5:03 am Ocular Therapeutix Q3 2022 Earnings Preview seekingalpha.com Nov 7, 2022 4:35 am
Ocular Therapeutix To Report Third Quarter 2022 Financial Results finance.yahoo.com Oct 24, 2022 6:00 am
Ocular Therapeutix Reports Fourth Quarter and Year End 2020 Financial Results and Business Update finance.yahoo.com Sep 30, 2022 4:01 pm
Ocular Therapeutix Reports Third Quarter 2021 Financial Results and Business Update finance.yahoo.com Sep 30, 2022 4:01 pm
Ocular Therapeutix Reports Fourth Quarter and Year-End 2021 Financial Results and Business Update finance.yahoo.com Sep 30, 2022 4:01 pm
Ocular Therapeutix To Present Pre-Clinical Data at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting finance.yahoo.com Sep 30, 2022 4:01 pm This company doesn't provide a dividend.
Talk about Ocular Therapeutix Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?